US Stock Movement | Reports indicate negotiations for acquisition with at least one large pharmaceutical company, Moderna rises over 9%
I'm PortAI, I can summarize articles.
On Thursday, Moderna's stock price rose, and as of the time of writing, the stock was up over 9%, trading at $26.95. On the news front, a person familiar with the discussions revealed that the company is in acquisition negotiations with at least one large pharmaceutical company for a large-scale deal
According to Zhitong Finance APP, on Thursday, Moderna (MRNA.US) shares rose, with the stock up over 9% as of the time of writing, priced at $26.95. On the news front, a person familiar with the discussions revealed that the company has been in acquisition negotiations for a large-scale deal with at least one major pharmaceutical company
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments